Active	Status	Sponsor type	Region	Phase	Filter
1 Active 7 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
NCT05177939: Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis	Recruiting	3	40	Japan	NPB-01, Intravenous immunoglobulin, NPB-01-ME, methylprednisolone sodium succinate	Nihon Pharmaceutical Co., Ltd	Autoimmune Encephalitis	05/24	10/24